期刊文献+

CD44v6和E-cadherin表达与肺癌的关系 被引量:3

Relationship between CD44v6,E-cadherin expression and lung cancer
下载PDF
导出
摘要 目的:探讨肺癌组织中CD44v6和E-钙黏附素(E-cadherin,E-CD)表达的临床意义及其相关性。方法:应用免疫组织化学方法检测65例肺癌组织中CD44v6和E-CD的表达情况,结合临床病理指标及病例随访结果进行研究分析。结果:在肺癌中CD44v6和E-CD表达阳性率分别为66.2%和53.8%。CD44v6高表达和E-CD低表达均与肺癌PTNM分期、病理分级和淋巴结转移呈正相关(均P<0.05)。肺癌CD44v6表达与E-CD表达呈负相关(r=-0.43,P<0.001)。结论:肺癌中CD44v6表达与E-CD表达密切相关,两者均可作为预测肺癌转移和评估预后的参考指标。 Objective: To study clinical significance of the expression of CD44v6 and E-cadherin(E-CD) in lung cancer and their correlation.Methods: Immunohistochemical method was used to investigate the expression of CD44v6 and E-CD protein in 65 cases of lung cancer.Results: The positive expression rate of CD44v6 and E-CD was 66.2% and 53.8% respectively in lung cancer.The overexpression of CD44v6 and the low expression of E-CD were correlated with pathological tumor node meyastasis stage,pathology grade and lymph node metastasis(all P0.05).CD44v6 expression was negatively correlated with E-CD expression in lung cancer(r=-0.43,P0.001).Conclusion: CD44v6 and E-CD expression have significant correlation in lung cancer.The expression of CD44v6 or E-CD is important index to evaluate the metastasis and prognosis of lung cancer.
作者 谷化平
出处 《东南大学学报(医学版)》 CAS 2010年第2期203-205,共3页 Journal of Southeast University(Medical Science Edition)
关键词 肺癌 CD44V6 E-钙黏附素 免疫组织化学 lung cancer CD44v6 E-cadherin immunohistochemistry
  • 相关文献

参考文献8

二级参考文献22

共引文献72

同被引文献39

  • 1Zheng, Yao,Wang, Lin,Zhang, Jian-Ping,Yang, Jing-Yan,Zhao, Zhu-Mei,Zhang, Xiao-Ying.Expression of p53,c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma[J].World Journal of Gastroenterology,2010,16(3):339-344. 被引量:34
  • 2陈昊,李玉民,何明彦,李汛,周文策,孟文勃,张磊.胃不典型增生和癌组织中Ki67和PTEN蛋白的表达及意义[J].中国普外基础与临床杂志,2007,14(3):304-307. 被引量:18
  • 3LEE S,CHOI E J,JIN C, et al. Activation of PI3K/Akt path- way by PTEN reduction and PIK3CA mRNA amplification con- tributes to cisplatin resistance in an ovarian cancer cell line [ J ]. Gynecologic Ontology, 2005,97 : 26- 34.
  • 4GOMES C P, ANDRADE L A. PTEN and p53 expression in primary ovarian carcinomas: immunohistochemical study and discussion of pathogenetic mechanisms [ J ]. Int J Gynecol Cancer, 2006,16 : 254 - 258.
  • 5LEONARDO E, VOLANTE M, BARBARESCHI M, et al. Cell membrane reactivity of MIB- 1 antibody to Ki67 in human tumors:fact or artifact [ J ]. Appl Immunohistochem Mol Mor- phol,2007,15 (2) : 220- 225.
  • 6van RIJN S J,GRINWIS G C,PENNING L C, et al. Expression of Ki-67, PCNA,and p27kipl in canine pituitary corticotroph adenomas [ J ]. Domest Anim Endocrinol, 2010, 38 ( 4 ): 244-252.
  • 7] WANG Y,WANG X,ZHANG J,et al. MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas [ J ]. J Neurooncol, 2012,106(2) :217-224.
  • 8YOSHIMOTO M, CUTZ J C, NUIN P A, et al. Interphase FISH analysis of PTEN in histologic of sections shows ge- nomic deletions in 68% of primary prostate cancer and 23% high- grade prosraticintra- epithelial neoplasias [ J ]. Cancer Genet Cvtoenet .2006.169,128-137.
  • 9GALLARDO A, LERMA E, ESCUIN D, et al. Increased sig- nalling of EGFR and IGF1R, and deregulation of FFEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas [ J ]. Br J Cancer, 2012,106 ( 8 ) : 1367-1373.
  • 10KINROSS K M, MONTGOMERY K G, KLEINSCHMIDT M, et al. An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice[ J]. J Clin Invest, 2012,122 ( 2 ) : 553-557.

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部